News
HSBC analyst Frank Lee just upgraded Advanced Micro Devices (AMD) from “Hold” to “Buy,” doubling its price target from $100 to $200 per share, implying a 44.5% upside from the stock’s closing price of ...
3h
Zacks Investment Research on MSNWhich Brokerage Stock Will Lead Tomorrow: Robinhood or Schwab?As the investing landscape evolves at breakneck speed, two online brokerage giants — Robinhood Markets HOOD and Charles Schwab SCHW — stand at the forefront of a financial transformation targeting ...
On July 8, 2025, trading in Chipotle call options exploded, with volume soaring to a level 145.8% above its daily average.
Traders have repeatedly shrugged off President Trump’s disruptive tariff wars and fiscal policy, pushing U.S. stock prices ...
BNP's strategy note "Running It Hot" predicts the S&P 500 at 6,700 12 months out, with Eurostoxx 600 rising to 590.
Discover how Citadel Securities solidifies its dominance in market-making with a key acquisition from Morgan Stanley.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Meta’s $100 million sign-up bonuses have underscored the value of cutting-edge tech talent. Indian businesses should also be ...
Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...
After Glenmark’s landmark $2 billion licensing deal with US major AbbVie for its cancer drug, ISB 2001, the stock hit the 10% ...
The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results